2025 Interventional Pulmonary - Diagnostic & Therapeutic Bronchoscopy


2025 Interventional Pulmonary - Diagnostic & Therapeutic Bronchoscopy Banner



Date & Location
Wednesday, April 2, 2025, 8:00 AM - Saturday, April 5, 2025, 1:00 PM, Lahey Hospital & Medical Center, Burlington, MA

Credits
AMA PRA Category 1 Credits™ (27.00 hours), Non-Physician Attendance (27.00 hours)

Overview

This activity is designed to provide participants with an in-depth understanding of various advanced bronchoscopy techniques and their applications in the management of airway and pleural diseases. Through expert discussions and case-based learning, attendees will gain knowledge on the indications, contraindications, and techniques for procedures such as laser applications, argon plasma coagulation, electrocautery, cryotherapy, and cryobiopsies. Participants will also explore the physiology of central airway obstruction, the role of advanced diagnostic tools like TBNA, EBUS, and pleural interventions, as well as the updated lung cancer staging guidelines. By the end of this activity, participants will be better equipped to manage both benign and malignant airway diseases, perform advanced bronchoscopic procedures, and enhance their understanding of lung cancer diagnosis and staging.


Objectives

Following the activity, attendees should be able to:


  1. Identify the indications and contraindications and proper technique of applications of the above procedures.
  2. Discuss the basic principles of laser application, argon plasma coagulation,electrocautery and cryotherapy and cryobiopsies.
  3. Describe the physiology of central airway obstruction and how it can be modified by various endoscopic therapies and airway stenting.
  4. Management of both benign and malignant airway diseases.
  5. Define the role of TBNA, EBUS, and other modalities of advanced bronchoscopy in the diagnosis and staging of lung cancer.
  6. Describe the pleural anatomy and the indications and contraindications of medical thoracoscopy and indwelling pleural catheters in benign and malignant pleural disease.
  7. Explain the indications and technique of percutaneous dilatational tracheostomy
  8. Define management strategy for hemoptysis
  9. Understand the updated lung cancer staging guidelines and risk stratification of the lung nodule
  10. Understand the role of rigid bronchoscopy.
  11. Identify cytology and molecular markers for lung cancer.
  12. Identify the aspects of navigation bronchoscopy and minimally invasive robotic bronchoscopic navigation as well as comprehensive management of lung nodules. Additionally:

Accreditation

Lahey Clinic Hospital, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lahey Clinic Hospital, Inc. designates this live activity for a maximum of 27 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

Cancellation Policy

Please note that cancellation fees vary depending on the activity. Cancellations must be received by March 4, 2025. After this date, a refund will not be guaranteed unless a replacement is found. There will be a $375 fee for all cancellations prior to February 24, 2025. If you have any questions, please contact us at kim.e.scroxton@lahey.org

Accessibility Statement
 
Lahey Clinical Hospital Inc. is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.